Concepedia

Publication | Open Access

Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

DOIFull Paper Access

26

Citations

22

References

2022

Year

Maria Martinez‐García, Guillermo Velasco, Estela Pineda, Miguel Gil‐Gil, Francesc Alameda, Jaume Capellades, Mari Cruz Martín-Soberón, Israel López-Valero, Elena Tovar Ambel, P. Foro,
Cancers

Abstract

The addition of crizotinib to standard RT and TMZ for newly diagnosed GBM was safe and the efficacy was encouraging, warranting prospective validation in an adequately powered, randomized controlled study.

References

YearCitations

Page 1